Placental pathology, corticotropin-releasing hormone, timing of parturition, and fetal growth in the pregnancy outcomes and community health study

References

• Stanek J. Comparison of placental pathology in preterm, late-preterm, near-term, and term births. Am J Obstet Gynecol. 2014;210:234.e1–234.e6.
   Web of Science ®Google Scholar
• Kim YM, Chaemsaithong P, Romero R, et al. The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion. J Matern Fetal Neonatal Med. 2015;28:2001–2009.
   PubMed Web of Science ®Google Scholar
• Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension. 2013;62:1046–1054.
   PubMed Web of Science ®Google Scholar
• Holzman C, Jetton J, Siler-Khodr T, et al. Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstet Gynecol. 2001;97:657–663.
   PubMed Web of Science ®Google Scholar
• Hobel CJ, Dunkel-Schetter C, Roesch SC, et al. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks’ gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol. 1999;180:S257–S263.
   PubMed Web of Science ®Google Scholar
• McLean M, Bisits A, Davies J, et al. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations. Am J Obstet Gynecol. 1999;181:207–215.
   PubMed Web of Science ®Google Scholar
• Warren WB, Patrick SL, Goland RS. Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor. Am J Obstet Gynecol. 1992;166:1198–204.
   PubMed Web of Science ®Google Scholar
• Korebrits C, Ramirez MM, Watson L, et al. Maternal corticotropin-releasing hormone is increased with impending preterm birth. J Clin Endocrinol Metab. 1998;83:1585–1591.
   PubMed Web of Science ®Google Scholar
• Bisits A, Madsen G, McLean M, et al. Corticotropin-releasing hormone: a biochemical predictor of preterm delivery in a pilot randomized trial of the treatment of preterm labor. Am J Obstet Gynecol. 1998;178:862–866.
   PubMed Web of Science ®Google Scholar
• Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol. 2004;191:1063–1069.
   PubMed Web of Science ®Google Scholar
• Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept. 2002;108:159–164.
   PubMedGoogle Scholar
• Makrigiannakis A, Zoumakis E, Kalantaridou S, et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol. 2001;2:1018–1024.
   PubMed Web of Science ®Google Scholar
• Ferrari A, Petraglia F, Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J Steroid Biochem Mol Biol. 1995;54:251–255.
   PubMed Web of Science ®Google Scholar
• Karteris E, Papadopoulou N, Grammatopoulos DK, et al. Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. J Mol Endocrinol. 2004;32:21–32.
   PubMed Web of Science ®Google Scholar
• Choy MY, Leung TN, Lau TK. Corticotropin-releasing hormone peptide and human first-trimester placental growth. Early Hum Dev. 2004;79:77–80.
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab. 1994;79:666–669.
   PubMed Web of Science ®Google Scholar
• Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet. 1999;354:1546–1549.
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway. J Clin Endocrinol Metab. 1995;80:2888–2893.
   PubMed Web of Science ®Google Scholar
• Holzman C, Bullen B, Fisher R, et al. Pregnancy outcomes and community health: the POUCH study of preterm delivery. Paediatr Perinat Epidemiol. 2001;15:136–158.
   PubMed Web of Science ®Google Scholar
• Holzman C, Fisher R, Jetton J, et al. Maternal serum alpha fetoprotein levels, preterm delivery, and fetal growth among White and African-American women. Presented at the Society for Pediatric and Perinatal Epidemiologic Research, Snowbird, Utah Paediatric and Perinatal Epidemiology; 1995.
   Google Scholar
• Waller DK, Lustig LS, Cunningham GC et al. Obstet Gynecol. 1996; 88(5):816–22.
   PubMed Web of Science ®Google Scholar
• Kelly R, Holzman C, Senagore P, et al. Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol. 2009;170:148–158.
   PubMed Web of Science ®Google Scholar
• Talge NM, Mudd LM, Sikorskii A, et al. United States birth weight reference corrected for implausible gestational age estimates. Pediatrics. 2014;133:844–853.
   PubMed Web of Science ®Google Scholar
• Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta. 2003;24:S21–SS27.
   PubMed Web of Science ®Google Scholar
• Ødegård RA, Vatten LJ, Nilsen ST, et al. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96:950–955.
   PubMed Web of Science ®Google Scholar
• Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion. 1990;30:344–357.
   PubMed Web of Science ®Google Scholar
• Rudge MV, Lima CP, Damasceno DC, et al. Histopathological placental lesions in mild gestational hyperglycemic and diabetic women. Diabetol Metab Syndr. 2011;3:19.
   PubMed Web of Science ®Google Scholar
• Fox H. Pathology of the placenta in maternal diabetes mellitus. Obstet Gynecol. 1969;34:792–798.
   PubMed Web of Science ®Google Scholar
• Talge NM, Holzman C, Senagore PK, et al. Biological indicators of the in-utero environment and their association with birth weight for gestational age. J Dev Orig Health Dis. 2011;2:280–290.
   PubMed Web of Science ®Google Scholar
• Nkwabong E, Kamgnia Nounemi N, Sando Z, et al. Risk factors and placental histopathological findings of term born low birth weight neonates. Placenta. 2015;36:138–141.
   PubMed Web of Science ®Google Scholar
• Salim R, Jubran J, Okopnik M, et al. Do placental lesions among term small for gestational age newborns differ according to the clinical presentation? Eur J Obstet Gynecol Reprod Biol. 2014;173:38–42.
   PubMed Web of Science ®Google Scholar
• Becroft DM, Thompson JM, Mitchell EA. The epidemiology of placental infarction at term. Placenta. 2002;23:343–351.
   PubMed Web of Science ®Google Scholar
• Ananth CV, Berkowitz GS, Savitz DA, et al. PLacental abruption and adverse perinatal outcomes. JAMA. 1999;282:1646–1651.
   PubMed Web of Science ®Google Scholar
• Salafia CM, Minior VK, Pezzullo JC, et al. Intrauterine growth restriction in infants of less than thirty-two weeks’ gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995;173:1049–1057.
   PubMed Web of Science ®Google Scholar
• Yang X, Hsu-Hage B, Zhang H, et al. Women with impaired glucose tolerance during pregnancy have significantly poor pregnancy outcomes. Diabetes Care. 2002;25:1619–1624.
   PubMed Web of Science ®Google Scholar
• Rosenberg TJ, Garbers S, Lipkind H, et al. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health. 2005;95:1545–1551.
   PubMed Web of Science ®Google Scholar
• Lao TT, Ho LF. Does maternal glucose intolerance affect the length of gestation in singleton pregnancies?. J Soc Gynecol Investig. 2003;10:366–371.
   PubMedGoogle Scholar
• Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol. 2003;102:850–856.
   PubMed Web of Science ®Google Scholar
• HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
   PubMed Web of Science ®Google Scholar
• HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–459.
   PubMed Web of Science ®Google Scholar
• Huynh J, Dawson D, Roberts D, et al. A systematic review of placental pathology in maternal diabetes mellitus. Placenta. 2015;36:101–114.
   PubMed Web of Science ®Google Scholar
• Coustan DR. Patient education: gestational diabetes mellitus (beyond the Basics). In: Nathan DM, Greene MF, editors. UpToDate; 2016.
   Google Scholar
• Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol. 1997;90:542–545.
   PubMed Web of Science ®Google Scholar
• Ogunyemi D, Murillo M, Jackson U, et al. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102–109.
   PubMedGoogle Scholar
• Goldenberg RL, Andrews WW, Faye-Petersen OM, et al. The Alabama preterm birth study: corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection. Am J Obstet Gynecol. 2006;195:1020–1024.
   PubMed Web of Science ®Google Scholar